ARTICLE | Company News
Catalytica, Rhone-Poulenc Rorer deal
October 11, 1999 7:00 AM UTC
CTAL's Catalytica Pharmaceuticals Inc. subsidiary will non-exclusively manufacture RPR's worldwide supply of Synercid injectable streptogramin antibiotic to treat certain serious bacterial infections. The product received FDA approval last month. ...